Correction to "Impact analysis of heart failure across European countries: an ESC-HFA position paper" and "Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan"
- PMID: 38211306
- PMCID: PMC10966236
- DOI: 10.1002/ehf2.14672
Correction to "Impact analysis of heart failure across European countries: an ESC-HFA position paper" and "Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan"
Erratum for
-
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan.ESC Heart Fail. 2022 Apr;9(2):1107-1117. doi: 10.1002/ehf2.13779. Epub 2022 Feb 5. ESC Heart Fail. 2022. PMID: 35122477 Free PMC article.
-
Impact analysis of heart failure across European countries: an ESC-HFA position paper.ESC Heart Fail. 2022 Oct;9(5):2767-2778. doi: 10.1002/ehf2.14076. Epub 2022 Jul 22. ESC Heart Fail. 2022. PMID: 35869679 Free PMC article. Review.
References
-
- Dini FL, Carluccio E, Bitto R, Ciccarelli M, Correale M, D'Agostino A, et al. Working Group on Heart Failure of the Italian Society of Cardiology. Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan. ESC Heart Fail 2022;9:1107‐1117. doi:10.1002/ehf2.13779 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources